Fibroblastic cells at the tumor invasion front have been shown to express RANKL and interleukin-6 (IL-6), both of which stimulate osteoclast differentiation and function, leading to progressive bone destruction [5,6,7]. The gene discussed is IL6; the disease is neoplasm.